197 related articles for article (PubMed ID: 16314802)
1. Effect of FTY720 on chronic cyclosporine nephropathy in rats.
Kim JY; Lim SW; Li C; Kim JS; Ahn KO; Yang HJ; Choi BS; Kim YS; Kim J; Bang BK; Yang CW
Transplantation; 2005 Nov; 80(9):1323-30. PubMed ID: 16314802
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
[TBL] [Abstract][Full Text] [Related]
3. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
Peters H; Martini S; Wang Y; Shimizu F; Kawachi H; Krämer S; Neumayer HH
Kidney Int; 2004 Oct; 66(4):1434-43. PubMed ID: 15458436
[TBL] [Abstract][Full Text] [Related]
4. Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy.
Shihab FS; Andoh TF; Tanner AM; Bennett WM
Am J Kidney Dis; 1997 Jul; 30(1):71-81. PubMed ID: 9214404
[TBL] [Abstract][Full Text] [Related]
5. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
[TBL] [Abstract][Full Text] [Related]
6. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy.
Li C; Yang CW; Park JH; Lim SW; Sun BK; Jung JY; Kim SB; Kim YS; Kim J; Bang BK
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F46-57. PubMed ID: 14519596
[TBL] [Abstract][Full Text] [Related]
7. Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine.
Li C; Yang CW; Kim WY; Jung JY; Cha JH; Kim YS; Kim J; Bennett WM; Bang BK
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F389-98. PubMed ID: 12529276
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy.
Shihab FS; Bennett WM; Tanner AM; Andoh TF
Kidney Int; 1997 Sep; 52(3):660-73. PubMed ID: 9291185
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW
J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.
Pichler RH; Franceschini N; Young BA; Hugo C; Andoh TF; Burdmann EA; Shankland SJ; Alpers CE; Bennett WM; Couser WG
J Am Soc Nephrol; 1995 Oct; 6(4):1186-96. PubMed ID: 8589285
[TBL] [Abstract][Full Text] [Related]
11. Blockade of angiotensin II with losartan attenuates transforming growth factor-beta1 inducible gene-h3 (betaig-h3) expression in a model of chronic cyclosporine nephrotoxicity.
Sun BK; Li C; Lim SW; Choi BS; Lee SH; Kim IS; Kim YS; Bang BK; Yang CW
Nephron Exp Nephrol; 2005; 99(1):e9-16. PubMed ID: 15637465
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
Yang CW; Ahn HJ; Kim WY; Li C; Kim HW; Choi BS; Cha JH; Kim YS; Kim J; Bang BK
Kidney Int; 2002 Jul; 62(1):20-30. PubMed ID: 12081560
[TBL] [Abstract][Full Text] [Related]
13. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Shihab FS; Yi H; Bennett WM; Andoh TF
Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of pravastatin on transforming growth factor beta1-inducible gene h3 expression in a rat model of chronic cyclosporine nephropathy.
Li C; Lim SW; Choi BS; Lee SH; Cha JH; Kim IS; Kim J; Yang CW
Am J Nephrol; 2005; 25(6):611-20. PubMed ID: 16308546
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy.
Lee SH; Li C; Lim SW; Ahn KO; Choi BS; Kim YS; Moon IS; Kim J; Bang BK; Yang CW
Am J Nephrol; 2005; 25(1):64-76. PubMed ID: 15746540
[TBL] [Abstract][Full Text] [Related]
16. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor J
Transplant Proc; 2007 Dec; 39(10):2992-6. PubMed ID: 18089307
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin attenuates inflammation, apoptosis and fibrosis in a rat model of cyclosporine-induced nephropathy.
Nam HK; Lee SJ; Kim MH; Rho JH; Son YK; Lee SM; Kim SE; Kim KH; An WS
Am J Nephrol; 2013; 37(1):7-15. PubMed ID: 23258196
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A sensitizes the kidney to tubulointerstitial fibrosis induced by renal warm ischemia.
Ahmed A; Huang L; Raftery AT; Ahmed AK; Fahmy H; El Nahas AM; Haylor JL
Transplantation; 2004 Mar; 77(5):686-92. PubMed ID: 15021830
[TBL] [Abstract][Full Text] [Related]
19. Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
Schaier M; Vorwalder S; Sommerer C; Dikow R; Hug F; Gross ML; Waldherr R; Zeier M
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F769-80. PubMed ID: 19535570
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats.
Chung BH; Li C; Sun BK; Lim SW; Ahn KO; Yang JH; Choi YH; Yoon KH; Sugawara A; Ito S; Kim J; Yang CW
Am J Transplant; 2005 Aug; 5(8):1856-67. PubMed ID: 15996232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
